$JSPR
Jasper Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$0.570
▼-10.11%-$0.064
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateJasper Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is JSPR down today? It is at $0.570 (-10.11%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment JSPR spikes, and full due diligence on JSPR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $JSPR 5 times in the last 30 days. Create a free account to track $JSPR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on JSPR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
Latest filingDEF 14AProxy statementSep 4, 2026 · 15 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Shizuru Judith Anne Director | Bought (open market) | +41K 0.1% of company | added 35% | 157K | $100K at $2.43 | Sep 22, 25 |
Martell Ron Officer | Bought (open market) | +41K 0.1% of company | added 100% | 74K | $100K at $2.43 | Sep 22, 25 |
Lucas Svetlana Director | Bought (open market) | +20K 0.06% of company | n/a | 20K | $49K at $2.43 | Sep 22, 25 |
Wiggans Thomas G Director | Bought (open market) | +41K 0.1% of company | n/a | 41K | $100K at $2.43 | Sep 22, 25 |
Mahal Jeetinder Singh Officer | Sold (automatic/other) | -900 | sold 3.5% | 25K | $20K at $22.11 | Dec 12, 24 |
Mahal Jeetinder Singh Officer | Other | 900 | added 3.6% | 26K | $6K at $7.10 | Dec 12, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on JSPR from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
JSPR last traded at $0.570, down 10.11% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Jasper Therapeutics, Inc. Common Stock (JSPR) is next expected to report earnings on Monday, November 9, 2026, about 50 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The JSPR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged JSPR 5 times in the last 30 days.
JSPR (Jasper Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $21M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge JSPR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$JSPR discussion
Sign in to ask a question or join the discussion.